Nephros Inc (NEPH)

NASDAQ

Currency in USD

3.550

+0.020(+0.57%)

Closed·31/07

After Hours

3.5500.000(0.00%)

·31/07

Fair Value

Unlock Value

Day's Range

3.450

3.770

52 wk Range

1.364

5.000

NEPH Financial Summary

A brief financial summary of Nephros Inc as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Key Ratios

P/E Ratio49.39

Price/Book4.28

Debt / Equity14.28%

Return on Equity9.17%

Dividend Yield0.00%

EBITDA143.00K

Fair ValueUnlock

Fair Value UpsideUnlock

Statements Highlights

Period Ending:

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

Income Statement

Total Revenues

aa.aa

8.56

10.22

9.98

14.24

14.16

Gross Profit

aa.aa

4.91

5.63

4.73

8.41

8.72

Operating Income

aa.aa

-4.5

-3.25

-4.34

-1.59

0.01

Net Income

aa.aa

-4.77

-4.11

-7.38

-1.58

0.07

Balance Sheet

Total Assets

aa.aa

18.51

17.65

11.86

11.21

Total Current Liabilities

aa.aa

1.33

2.39

1.41

2.11

1.56

Total Equity

aa.aa

15.57

14.75

8.88

8.36

8.59

Cash Flow

Levered Free Cash Flow

aa.aa

-5.54

0.7

-0.33

1.37

-0.65

Cash from Operations

aa.aa

-6.9

-1.42

-3.23

0.83

-0.49

Cash from Investing

aa.aa

-0.24

-0.09

-0.14

-0.08

-0.05

Cash from Financing

aa.aa

11.22

0.24

0.03

-0.08

-0.01

Net Change in Cash

aa.aa

4.08

-1.28

-3.34

0.67

-0.55

* In Millions of USD (except for per share items)

Analyst Ratings

2 Buy

0 Hold

0 Sell

Ratings:

2 analysts

Overall Consensus

Strong Buy

Analysts 12-Month Price Target:

Average 4.750

(+33.80% Upside)

Earnings

Latest Release

May 08, 2025

EPS / Forecast

0.05 / -0.005

Revenue / Forecast

4.88M / 3.65M

EPS Revisions

Unlock

Last 90 days

FAQ

What were Nephros's earnings for the latest quarter?

The Nephros EPS (TTM) is 0.08. Nephros reported sales of 4.88, net income of 0.56, and EPS of 0.05 for the latest quarter.

What was Nephros's net income for the latest quarter?

Nephros's net income for the latest quarter was 0.56.

How did Nephros's performance compare year-over-year in the latest quarter?

The company's revenue moved from 3.87 in the previous quarter to 4.88 in the latest quarter, and net income moved from 0.35 to 0.56 compared to the previous quarter.

What is Nephros's net profit margin on a TTM basis?

Nephros's trailing twelve months (TTM) net profit margin is 0.52%.

How does Nephros's debt to equity ratio compare to industry standards?

Nephros's total debt-to-equity ratio is 14.28%.

What is Nephros's return on investment on a TTM basis?

Nephros's trailing twelve months (TTM) return on investment (ROI) is 9.17%.

Did Nephros gain or lose cash last quarter?

In the latest quarter, Nephros's net change in cash was 0.32 million.

What were Nephros's total assets and liabilities in the latest quarter?

As of the latest quarter, Nephros reported total assets of 11.78 million and total liabilities of 1.52 million.

How has Nephros's total revenue grown this year?

Nephros's total revenue was 3.87 in the previous quarter and 4.88 in the latest quarter.

What is Nephros's gross margin on a TTM basis?

Nephros's trailing twelve months (TTM) gross margin is 62.45%.

What was Nephros's revenue per share for the latest quarter?

Nephros's revenue per share for the latest quarter was 34.16.

NSE 30

5,135.68

+25.42

+0.50%

NSE All Share

139,863.52

+584.85

+0.42%

US 30

44,121.50

-9.5

-0.02%

US 500

6,336.40

-3.2

-0.05%

FTSE 100

9,132.81

-4.13

-0.05%

DAX

24,065.47

-196.75

-0.81%

South Africa Top 40

90,781.37

-816.26

-0.89%

Market Movers

Name	Last	Chg. %	Vol.
Fidelitybk	21.050	+0.24%	81.12M
Guaranty Trust Holding	100.50	-1.42%	24.03M
Lafarge Africa	149.00	-1.32%	23.53M
Guinness Nigeria	117.05	+9.96%	13.30M
MTN Nigeria	472.00	+0.19%	5.89M
Dangote Cement	528.30	+3.67%	5.58M
Aradel Holdings	530.00	+3.09%	3.24M

Name	Last	Chg. %	Vol.
Wema Bank	22.00	+10.00%	22.15M
UAC Of Nigeria	80.30	+10.00%	1.59M
Guinness Nigeria	117.05	+9.96%	13.30M
Skyway Aviation Handling Company	90.05	+9.95%	2.66M
Mecure Industries	15.85	+9.69%	648.22K
Multverse	10.85	+9.60%	1.37M
Custodian Allied	36.00	+9.09%	2.41M

Name	Last	Chg. %	Vol.
Learn Africa	6.300	-10.00%	5.95M
Mansard Ins	11.700	-10.00%	12.84M
FTN Cocoa Processors PLC	5.67	-10.00%	13.85M
Initiates	13.50	-10.00%	4.51M
Ikeja	20.800	-9.96%	2.65M
Npfmcrfbk	3.080	-9.94%	6.74M
Nahco	99.100	-9.91%	3.83M

Trending Stocks

Name	Last	Chg. %	Vol.
UAC Of Nigeria	80.30	+10.00%	1.59M
Dangote Sugar	73.50	+3.30%	9.17M
Access Holdings	27.90	+1.09%	43.29M
Oando Plc	59.00	-0.51%	6.36M
Initiates	13.50	-10.00%	4.51M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaa A Aaa Aaaaaa	528.30	+38.51%	731.75
Aaaa A	5,450.00	+31.43%	7,162.94
Aaaaaaaaaaaaaa	67.00	+28.26%	85.93
Aaaaaa Aaaa Aaa	135.00	+20.66%	162.89

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers

Popular Searches

Please try another search

Nephros Inc (NEPH)

NEPH Financial Summary

Key Ratios

Statements Highlights

Analyst Ratings

Analysts 12-Month Price Target:

Earnings

FAQ

What were Nephros's earnings for the latest quarter?

What was Nephros's net income for the latest quarter?

How did Nephros's performance compare year-over-year in the latest quarter?

What is Nephros's net profit margin on a TTM basis?

How does Nephros's debt to equity ratio compare to industry standards?

What is Nephros's return on investment on a TTM basis?

Did Nephros gain or lose cash last quarter?

What were Nephros's total assets and liabilities in the latest quarter?

How has Nephros's total revenue grown this year?

What is Nephros's gross margin on a TTM basis?

What was Nephros's revenue per share for the latest quarter?

Trending Stocks